No abstract

Over the last few years, St. John's Wort products have enjoyed a tremendous surge in interest and sales for the therapy of mild to moderate depression. Although the complete spectrum of active substances in this herbal extract has not yet been elucidated, it is certain that hyperforin is an important component. Further, it appears that the hypericins may also contribute to the antidepressive activity. In this study, the content uniformity of eleven St. John's Wort products sold exclusively in pharmacies was determined. The main objective was to determine the batch-to-batch reproducibility of the various products. The hyperforin was analysed according to a previously published HPLC method, while the total hypericin content was determined by an electrochemical method. The results indicate that some, but not all, products show very reproducible batch-to-batch properties. Also, individual products have different hypericin and hyperforin levels, and are therefore not switchable--even when products are manufactured under similar extraction and processing conditions, have the same raw material:extract ratios (on a dry basis) and contain the same amount of extract per unit dosage form.

In contrast to chemically defined drugs, most herbal medicinal products (HMPs) are poorly characterized in terms of their pharmaceutical properties. In many cases it is assumed that the plant extract as a whole is the active moiety, since it is often difficult to identify the individual components responsible for the pharmacological activity and even more difficult to assess synergies among the various components. However, where the active components have been identified, it should be possible to compare products with respect not only to content uniformity but also to their biopharmaceutical properties. The aim of this study was to investigate and compare the dissolution characteristics of several St John's wort products under biorelevant conditions. Components of St John's wort known, or suspected, to play a role in its antidepressant activity include phloroglucines, naphthodianthrones and the flavonoids. Since these groups have a broad spectrum of polarity and solubility, dissolution was studied for representative compounds from each group. Although the labelling indicates that several of the products studied should be pharmaceutically equivalent, dissolution under biorelevant conditions revealed that they have quite different release profiles and cannot be considered switchable. It was concluded that biorelevant dissolution testing can be a powerful tool for comparing HMPs as well as synthetically produced drug products.

No abstract